410
Participants
Start Date
July 31, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
March 31, 2014
Everolimus
A 10-mg dose of everolimus was given by continuous oral daily dosing of two 5-mg tablets.
Everolimus Placebo
a 10-mg dose of matching placebo to Everolimus was given by continuous oral daily dosing of two 5-mg tablets.
Novartis Investigative Site, Taipei
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Brussels
Novartis Investigative Site, Brussels
Novartis Investigative Site, Leuven
Novartis Investigative Site, Zurich
Novartis Investigative Site, Taipei
Columbia University Medical Center- New York Presbyterian Dept. of Columbia Med. Center, New York
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Marseille
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Dijon
Novartis Investigative Site, Besançon
Levine Cancer Institute, Charlotte
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Lin-Ko
H. Lee Moffitt Cancer Center & Research Institute Malignant Hematology Clinic, Tampa
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Marburg
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2), Mobile
Novartis Investigative Site, Bologna
University of Louisville / James Graham Brown Cancer Center SC, Louisville
Novartis Investigative Site, Modena
Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept. of OHSU Medical Center, Columbus
Indiana University Health Goshen Center for Cancer Dept. of Indiana Univ. Cancer, Indianapolis
Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (4), Detroit
Novartis Investigative Site, Reims
University of Iowa Medical Center Dept. of Iowa Medical Center, Iowa City
Novartis Investigative Site, Mainz
Mayo Clinic - Rochester, Rochester
Novartis Investigative Site, Pisa
Novartis Investigative Site, Lille
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Lyon
LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Dept. of Neuroendocrine Clinic, New Orleans
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
The Center for Cancer and Blood Disorders, Fort Worth
Novartis Investigative Site, München
Cedars Sinai Medical Center SC-2, Los Angeles
University of California at Los Angeles UCLA (3), Los Angeles
Novartis Investigative Site, Songkhla
Novartis Investigative Site, Clichy
Pacific Cancer Medical Center, Inc., Anaheim
Novartis Investigative Site, Villejuif
Oregon Health & Science University Dept. of OHSU (3), Portland
Novartis Investigative Site, Bad Berka
University of California San Francisco Dept. of UCSF Comp. Cancer, San Francisco
Kaiser Permanente Northwest Franklin Medical Offices, Denver
St. Luke's Hospital and Health Network St. Luke's Cancer Network, Bethlehem
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Chuo-ku
Boston Medical Center BMC, Boston
Littleton Regional Hospital Dept. of Hematology/Oncology, Littleton
Fox Chase Cancer Center, Philadelphia
University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent, Houston
Novartis Investigative Site, Fortaleza
Novartis Investigative Site, Calgary
Novartis Investigative Site, Edmonton
Novartis Investigative Site, London
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Groningen
Novartis Investigative Site, Martin
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Withington
Novartis Investigative Site, Glasgow
Novartis Investigative Site, London
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY